Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01939301 · ClinicalTrials.gov registry record · Phase 2
Nitric Oxide to Treat Pulmonary Embolism
A Phase 2 study of Pulmonary Embolism, sponsored by Indiana University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
- 4
- Study locations
NCT01939301 is a Phase 2 study of Pulmonary Embolism that has completed, run by Indiana University School of Medicine. The registered enrollment target is 78 participants, below the 3,057-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT01939301, a Phase 2 study of Pulmonary Embolism, has completed, sponsored by Indiana University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a randomized study to treat subjects diagnosed with pulmonary embolism with inhaled nitric oxide or placebo (oxygen).
Conditions Studied
Interventions
- DRUG Sham
- DRUG Inhaled Nitric Oxide
Study Locations (4)
Indiana
- Eskenazi Hospital - Indianapolis
- Indiana University Hospital - Indianapolis
- Methodist Hospital - Indianapolis
Mississippi
- University of Mississippi - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01939301
The ClinicalTrials.gov registry entry for NCT01939301 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,057-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (97% lower). The listed sponsor is Indiana University School of Medicine, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT01939301 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Mississippi.
Frequently Asked Questions
What is clinical trial NCT01939301 about?
NCT01939301 is a clinical study titled "Nitric Oxide to Treat Pulmonary Embolism". This is a randomized study to treat subjects diagnosed with pulmonary embolism with inhaled nitric oxide or placebo (oxygen).
What is the current status of trial NCT01939301?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2013-10. Estimated completion is 2016-10-31.
What conditions does trial NCT01939301 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
What interventions are being tested in trial NCT01939301?
The interventions under investigation include: Sham (DRUG), Inhaled Nitric Oxide (DRUG).
Who is sponsoring clinical trial NCT01939301?
This trial is sponsored by Indiana University School of Medicine, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01939301 being conducted?
This trial has 4 study locations across Indiana, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
COMPLETED · Phase 2
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.